Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

61.99
+2.474.15%
Pre-market: 61.86-0.1300-0.21%07:21 EST
Volume:17.12M
Turnover:1.05B
Market Cap:126.20B
PE:17.92
High:62.05
Open:60.00
Low:59.77
Close:59.52
52wk High:63.33
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.04
T/O Rate:0.84%
Dividend:2.49
Dividend Rate:4.02%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.33%
ROA:9.39%
PB:6.80
PE(LYR):17.92

Loading ...

Bristol-Myers Squibb Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 06

BUZZ-Street View: Bristol Myers Squibb drug pipeline in focus as key patent expiry looms

Reuters
·
Feb 06

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 06

Bristol-Myers Squibb Company : Wells Fargo Raises Target Price to $60 From $55

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Citigroup Raises Target Price to $64 From $60

THOMSON REUTERS
·
Feb 06

Bristol-Myers Squibb Co : Morgan Stanley Raises Target Price to $40 From $37

THOMSON REUTERS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Reiterating Buy on Bristol-Myers Squibb: Milvexian’s Validated FXIa Mechanism and Underappreciated Stroke Prevention Upside Support $65 Target

TIPRANKS
·
Feb 06

Truist incrementally positive on Bristol Myers after Bayer asundexian data

TIPRANKS
·
Feb 06

JPMorgan Raises Bristol-Myers Squibb Price Target to $67 From $65

MT Newswires Live
·
Feb 06

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares

Reuters
·
Feb 06

Dow Tumbles Over 400 Points; Bristol Myers Reports Strong Q4 Results

Benzinga_recent_news
·
Feb 06

Bayer Says Asundexian Study Showed No Increase in the Risk of Major Bleeding

THOMSON REUTERS
·
Feb 06

Bayer Says Asundexian Reduced Ischemic Stroke by 26% in Phase Iii Oceanic-Stroke Study

THOMSON REUTERS
·
Feb 06

Bristol Myers Flags Data-Rich 2026 After Solid Quarter

Benzinga
·
Feb 05

Stock Track | Bristol-Myers Squibb Soars 5.06% Intraday on Strong Q4 Earnings and Upbeat 2026 Guidance

Stock Track
·
Feb 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 05

Sector Update: Health Care Stocks Lean Lower Premarket Thursday

MT Newswires Live
·
Feb 05

Bristol Myers Exec Says Co Expects 2027 Eliquis Sales Compared to 2026 to Show a Step Down in the Range of $1.5 Billion to $2 Billion - Conf Call

THOMSON REUTERS
·
Feb 05

Bristol Myers Squibb Shares up 1.5% Premarket After Forecasting 2026 Profit Above Estimates

THOMSON REUTERS
·
Feb 05